SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-217649
Filing Date
2020-08-12
Accepted
2020-08-12 16:06:03
Documents
12
Period of Report
2020-08-12
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K d90800d8k.htm   iXBRL 8-K 22008
  Complete submission text file 0001193125-20-217649.txt   139885

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA eypt-20200812.xsd EX-101.SCH 3076
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE eypt-20200812_lab.xml EX-101.LAB 17374
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE eypt-20200812_pre.xml EX-101.PRE 10957
5 EXTRACTED XBRL INSTANCE DOCUMENT d90800d8k_htm.xml XML 3232
Mailing Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472
Business Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472 617-926-5000
EyePoint Pharmaceuticals, Inc. (Filer) CIK: 0001314102 (see all company filings)

IRS No.: 262774444 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-51122 | Film No.: 201095504
SIC: 3826 Laboratory Analytical Instruments